These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 21644473)
1. Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines. Maghanoy A; Mallari I; Balagon M; Saunderson P Lepr Rev; 2011 Mar; 82(1):65-9. PubMed ID: 21644473 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy. Ravanes JM; Cellona RV; Balagon M; Abalos RM; Walsh GP; Walsh DS Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):323-30. PubMed ID: 21710853 [TBL] [Abstract][Full Text] [Related]
3. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil. Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027 [TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients. Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888 [TBL] [Abstract][Full Text] [Related]
5. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. Balagon MF; Cellona RV; Cruz Ed; Burgos JA; Abalos RM; Walsh GP; Saunderson PR; Walsh DS Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628 [TBL] [Abstract][Full Text] [Related]
6. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia. Guerrero-Guerrero MI; Muvdi-Arenas S; León-Franco CI Lepr Rev; 2012 Sep; 83(3):247-60. PubMed ID: 23356026 [TBL] [Abstract][Full Text] [Related]
7. Six years' follow-up of multibacillary leprosy patients treated with uniform multi-drug therapy in China. Shen J; Yan L; Yu M; Li J; Yu X; Zhang G Int J Dermatol; 2015 Mar; 54(3):315-8. PubMed ID: 25265933 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [TBL] [Abstract][Full Text] [Related]
9. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
10. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years. Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283 [TBL] [Abstract][Full Text] [Related]
12. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases. Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy. Balagon MF; Cellona RV; Abalos RM; Gelber RH; Saunderson PR Lepr Rev; 2010 Mar; 81(1):27-33. PubMed ID: 20496567 [TBL] [Abstract][Full Text] [Related]
14. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Jing Z; Zhang R; Zhou D; Chen J Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621 [TBL] [Abstract][Full Text] [Related]
19. Fixed-duration multidrug therapy in multibacillary leprosy. Li HY; Hu LF; Wu PW; Luo JS; Liu XM Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596 [TBL] [Abstract][Full Text] [Related]
20. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years. Norman G; Joseph G; Richard J Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]